Literature DB >> 7589854

Growth factor/matrix-induced proliferation of human adult beta-cells.

A Hayek1, G M Beattie, V Cirulli, A D Lopez, C Ricordi, J S Rubin.   

Abstract

Proliferation of human beta-cells in vitro is desirable for both transplantation and biological studies. In this study, human pancreatic islets obtained from cadavers were kept in tissue culture plates that favored cell attachment. When the cells attached to the matrix produced by the rat-bladder carcinoma cell line 804G, 5'-bromo-2'-deoxyuridine (BrdU) labeling increased from 4.7 +/- 2.5 to 13.2 +/- 2.2%, while cells simultaneously labeled for insulin and BrdU increased from 0 to 32%. Addition of the growth factor hepatocyte growth factor/scatter (HGF/SF) increased BrdU labeling to 17.5 +/- 1.8 and the percentage of double positive (BrdU + insulin) cells to 69%. This is the first in vitro demonstration that human beta-cells grown in monolayer culture are able to replicate when exposed to selected matrices and growth factors. These experiments add further evidence that HGF/SF is an important mitogenic agent for human beta-cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589854     DOI: 10.2337/diab.44.12.1458

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  34 in total

1.  Expanding human beta cells.

Authors:  R Scharfmann
Journal:  Diabetologia       Date:  2008-02-15       Impact factor: 10.122

Review 2.  beta-cell Regeneration: neogenesis, replication or both?

Authors:  Fred Levine; Pamela Itkin-Ansari
Journal:  J Mol Med (Berl)       Date:  2007-10-06       Impact factor: 4.599

3.  Adipose tissue-derived mesenchymal stem cells rescue the function of islets transplanted in sub-therapeutic numbers via their angiogenic properties.

Authors:  Gang Ren; Melika Rezaee; Mehdi Razavi; Ahmed Taysir; Jing Wang; Avnesh S Thakor
Journal:  Cell Tissue Res       Date:  2019-02-01       Impact factor: 5.249

4.  Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans.

Authors:  J J Meier; A E Butler; R Galasso; R A Rizza; P C Butler
Journal:  Diabetologia       Date:  2006-09-23       Impact factor: 10.122

Review 5.  Extracellular Matrix Scaffold Technology for Bioartificial Pancreas Engineering: State of the Art and Future Challenges.

Authors:  Marcus Salvatori; Ravi Katari; Timil Patel; Andrea Peloso; Jon Mugweru; Kofi Owusu; Giuseppe Orlando
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

Review 6.  Alternatives to unmodified human islets for transplantation.

Authors:  Alberto Hayek; Gillian M Beattie
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

7.  Proliferation of sorted human and rat beta cells.

Authors:  G Parnaud; D Bosco; T Berney; F Pattou; J Kerr-Conte; M Y Donath; C Bruun; T Mandrup-Poulsen; N Billestrup; P A Halban
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

8.  Parathyroid hormone-related protein enhances human ß-cell proliferation and function with associated induction of cyclin-dependent kinase 2 and cyclin E expression.

Authors:  Nagesha Guthalu Kondegowda; Sheela Joshi-Gokhale; George Harb; Katoura Williams; Xiao Ying Zhang; Karen K Takane; Pili Zhang; Donald K Scott; Andrew F Stewart; Adolfo Garcia-Ocaña; Rupangi C Vasavada
Journal:  Diabetes       Date:  2010-09-28       Impact factor: 9.461

9.  Generation of functional insulin-producing cells from mouse embryonic stem cells through 804G cell-derived extracellular matrix and protein transduction of transcription factors.

Authors:  Taku Kaitsuka; Hirofumi Noguchi; Nobuaki Shiraki; Takuya Kubo; Fan-Yan Wei; Farzana Hakim; Shoen Kume; Kazuhito Tomizawa
Journal:  Stem Cells Transl Med       Date:  2013-11-29       Impact factor: 6.940

10.  Epithelial-mesenchymal transition in cells expanded in vitro from lineage-traced adult human pancreatic beta cells.

Authors:  Holger A Russ; Philippe Ravassard; Julie Kerr-Conte; Francois Pattou; Shimon Efrat
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.